Lifeward (LFWD) announced the Company has completed its research program as part of the Israel Innovation Authority’s, IIA, MAGNET incentive program, the Human Robot Interaction Consortium. This three-year program provides research and collaboration grants to private businesses and leading academic centers, with the goal of “developing advanced technologies aimed at providing robots with social capabilities, enabling them to carry out various tasks and effective interactions with different users in diverse operational environments.” Through its work with the HRI Consortium, Lifeward examined how artificial intelligence could be utilized with future generations of its ReWalk Personal Exoskeleton. The Company successfully demonstrated a proof-of-concept prototype that integrated advanced sensing technologies and AI to enable autonomous decision making to adapt to different use environments. This effort showed how AI can improve exoskeleton device usability and advance future iterations of the exoskeleton.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LFWD:
- LFWD Upcoming Earnings Report: What to Expect?
- Lifeward announces U.S. insurance company approved payment for ReWalk 7
- Lifeward says Israeli soldier walks again with ReWalk Personal Exoskeleton
- Lifeward launches sales of ReWalk 7 Personal Exoskeleton in the U.S.
- Lifeward Announces Termination of Chief Sales Officer